Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 08, 2022

BUY
$117.13 - $176.59 $156,954 - $236,630
1,340 New
1,340 $231,000
Q1 2022

Apr 12, 2022

SELL
$126.46 - $235.05 $1.59 Million - $2.96 Million
-12,600 Closed
0 $0
Q4 2021

Jan 12, 2022

SELL
$225.82 - $368.51 $107,264 - $175,042
-475 Reduced 20.88%
1,800 $399,000
Q4 2021

Jan 12, 2022

BUY
$225.82 - $368.51 $2.44 Million - $3.98 Million
10,800 Added 600.0%
12,600 $2.79 Million
Q3 2021

Oct 12, 2021

SELL
$221.9 - $484.47 $34,394 - $75,092
-155 Reduced 6.38%
2,275 $694,000
Q1 2021

May 21, 2021

BUY
$109.18 - $185.98 $265,307 - $451,931
2,430 New
2,430 $371,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Stonnington Group, LLC Portfolio

Follow Stonnington Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonnington Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stonnington Group, LLC with notifications on news.